Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sunshine Biopharma (SBFM) Shares Outstanding (Diluted Average) (2021 - 2025)

Historic Shares Outstanding (Diluted Average) for Sunshine Biopharma (SBFM) over the last 5 years, with Q1 2025 value amounting to $2.7 million.

  • Sunshine Biopharma's Shares Outstanding (Diluted Average) rose 32152.67% to $2.7 million in Q1 2025 from the same period last year, while for Mar 2025 it was $2.7 million, marking a year-over-year increase of 32152.67%. This contributed to the annual value of $701749.0 for FY2024, which is 537172.71% up from last year.
  • Sunshine Biopharma's Shares Outstanding (Diluted Average) amounted to $2.7 million in Q1 2025, which was up 32152.67% from $701749.0 recorded in Q4 2024.
  • Over the past 5 years, Sunshine Biopharma's Shares Outstanding (Diluted Average) peaked at $25.7 million during Q3 2023, and registered a low of $12825.0 during Q4 2023.
  • Its 5-year average for Shares Outstanding (Diluted Average) is $9.4 million, with a median of $4.0 million in 2022.
  • Per our database at Business Quant, Sunshine Biopharma's Shares Outstanding (Diluted Average) crashed by 9991.55% in 2023 and then skyrocketed by 537172.71% in 2024.
  • Sunshine Biopharma's Shares Outstanding (Diluted Average) (Quarter) stood at $2.6 million in 2021, then skyrocketed by 481.18% to $15.2 million in 2022, then crashed by 99.92% to $12825.0 in 2023, then skyrocketed by 5371.73% to $701749.0 in 2024, then surged by 285.22% to $2.7 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $2.7 million in Q1 2025, compared to $701749.0 in Q4 2024 and $641310.0 in Q1 2024.